Why all clinical trial results must be published
21 February 2013
This week the British Biotech company
Phytopharm announced that their new Parkinson's drug Cogane
failed in Phase 2 clinical trials. This is disappointing news but
it's crucial that negative results like these are made public.
For research to be beneficial for people with Parkinson's, the findings must be shared.
That's why we're supporting the All Trials Registered, All Results Reported campaign.
In the 28-week trial which involved more than 400 people with
Parkinson's, participants taking Cogane
showed no benefit compared to those taking placebo (or dummy
Research is only useful when the results are shared
Clinical research into Parkinson's is crucial if we're to
understand more about the condition and ultimately find a cure.
But the evidence suggests that about half of all clinical trials
have never been published, and trials with negative results are
even less likely to be made public.
In order for clinical research to be beneficial for people with
Parkinson's, the findings must be shared.
So while the findings from the Cogane trial are not what we
hoped for, at least they have been made available for others to
learn from them.
That's why we're supporting the All Trials Campaign
The All Trials initiative is campaigning for the publication of
the results from all clinical trials - past, present and future -
on all treatments currently being used.
Please support the campaign by signing the All Trials petition.
Rachel Evans, our clinical research policy and campaigns
"We believe that the results of every Parkinson's trial should
be made public regardless of the findings.
"That's why we've signed up to support the All Trials Registered, All Results
"If you'd like to support the campaign, you can add your name to
the All Trials online petition.
"We're also working closely with other research charities to
make sure that new rules being developed to govern clinical
trials across Europe - the EU Clinical Trials Regulation - make
reporting results mandatory."